FDA Approved: JANUVIA — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approves JANUVIA (sitagliptin) under the original application from Merck Sharp & Dohme LLC for the treatment of type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

ORIG AP for JANUVIA (SITAGLIPTIN)